# Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025
Canonical URL: https://biopharmsignal.com/news/RPTX/repare-therapeutics-announces-six-abstracts-accepted-for-presentation-at-aacr-annual-meeting-2025
Ticker: RPTX
Company: Repare Therapeutics
Source: Repare Therapeutics
Published: 2025-04-25 17:00 EST
Original Source URL: https://ir.reparerx.com
## Summary

CAMBRIDGE, Mass. & MONTREAL --(BUSINESS WIRE)--Apr. 25, 2025-- Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the acceptance of two abstracts for mini-oral presentation and the acceptance of four abstracts

## Article Body
CAMBRIDGE, Mass. & MONTREAL --(BUSINESS WIRE)--Apr. 25, 2025-- Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the acceptance of two abstracts for mini-oral presentation and the acceptance of four abstracts
## Recent Company News
- 2026-01-16 21:58 EST — [Repare Shareholders Approve Acquisition by XenoTherapeutics, Inc.](https://biopharmsignal.com/news/RPTX/repare-shareholders-approve-acquisition-by-xenotherapeutics-inc) — Source: Repare Therapeutics
- 2025-12-24 12:00 EST — [Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration](https://biopharmsignal.com/news/RPTX/repare-therapeutics-announces-acquisition-of-pol-atpase-inhibitor-rp-3467-by-gilead-sciences-for-up-to-30-million-in-total-consideration) — Source: Repare Therapeutics
- 2025-11-20 22:25 EST — [Repare Therapeutics Enters into Support and Voting Agreements with Significant Shareholders for Proposed Transaction with XenoTherapeutics, Inc.](https://biopharmsignal.com/news/RPTX/repare-therapeutics-enters-into-support-and-voting-agreements-with-significant-shareholders-for-proposed-transaction-with-xenotherapeutics-inc) — Source: Repare Therapeutics
- 2025-11-14 21:44 EST — [Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc.](https://biopharmsignal.com/news/RPTX/repare-therapeutics-enters-into-definitive-agreement-to-be-acquired-by-xenotherapeutics-inc) — Source: Repare Therapeutics
- 2025-10-13 20:05 EST — [Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics](https://biopharmsignal.com/news/RPTX/repare-therapeutics-to-present-initial-data-from-phase-1-lions-clinical-trial-at-37th-aacr-nci-eortc-international-conference-on-molecular-targets-and-cancer-therapeutics) — Source: Repare Therapeutics
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)